Chronic Myelomonocytic Leukemia
Also known as: Chronic Myelomonocytic Leukemia (CMML) / Chronic myelomonocytic leukaemia / CMML / Leukemia, Myelomonocytic, Chronic / Chronic myelomonocytic leukemia not having achieved remission / Chronic myelomonocytic leukemia (morphologic abnormality) / Chronic myelomonocytic leukemia (disorder) / Chronic myelomonocytic leukemia -RETIRED- / Chronic myelomonocytic leukemia [dup] (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00928 | Azacitidine | A pyrimidine nucleoside analogue used to treat certain subtypes of myelodysplastic syndrome. |
DB15694 | Cedazuridine | A cytidine deaminase inhibitor coadministered with the hypomethylating agent decitabine for the treatment of variable forms of myelodysplastic syndrome (MDS). |
DB01262 | Decitabine | A chemotherapeutic pyrimidine nucleoside analogue used for the treatment of myelodysplastic syndromes (MDS) by inducing DNA hypomethylation and corresponding alterations in gene expression. |